Compugen Ltd., a leading biotechnology company headquartered in Israel (IL), has been at the forefront of immuno-oncology since its establishment in 1993. With a strong focus on discovering and developing innovative therapeutic solutions, Compugen operates primarily in the fields of cancer immunotherapy and autoimmune diseases. The company is renowned for its unique approach to drug discovery, leveraging proprietary computational biology platforms to identify novel targets and biomarkers. Compugen's core products include monoclonal antibodies and immune checkpoint inhibitors, which have shown promising results in clinical trials. With a robust pipeline and strategic partnerships, Compugen has positioned itself as a key player in the biotechnology sector, continually striving to advance patient care through cutting-edge research and development.
How does Compugen Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Compugen Ltd.'s score of 23 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Compugen Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Compugen Ltd. may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Compugen Ltd. aligns with these industry standards. As the company continues to operate, it may consider developing and communicating its climate strategy to enhance transparency and accountability in its environmental impact.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Compugen Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.